摘要: |
[目的] 调查本地区心肌梗死患者出院后用药情况,分析影响其正确用药的原因。 [方法] 总结大连瓦房店市中心医院2000年至2003年116例急性心肌梗死患者出院1年内抗血小板药、血管转换酶抑制剂(ACEI)、β-受体阻滞剂、调脂药和其他药物用药情况。[结果] 108例(93.1%)患者常规口服抗血小板药物,存在主要问题是部分患者用量偏低;75例(64.7%)患者服用ACEI;82例(70.7%)患者常规口服β-受体阻滞剂,心率达标率为39%;只有39例(33.6%)患者坚持服用调脂药;26例患者无症状长期口服硝酸酯类药物;24例患者长期口服钙通道阻滞剂(CCB)。 [结论] 抗血小板药物和β-受体阻滞剂使用率较好,存在主要问题是用量低,主要原因是随诊不够;影响ACEI使用率主要因为咳嗽等副作用,其次存在医师的认识问题;影响调脂药物的使用率和用量的主要原因是经济问题。 |
关键词: 心肌梗死 规范用药 调查分析 |
DOI:10.11724/jdmu.2006.03.31 |
分类号:R541 |
基金项目: |
|
Investigation of post-discharge medications of 116 patients with myocardial infarction in Wafangdian |
LANG Jiu-li
|
Dalian Wafangdian Center Hospitol, Dalian 116000,China
|
Abstract: |
[Objective] To survey the post-discharge medications of 116 patients with myocardial infarction in Dalian Wafangdian and analyze the reasons for influencing their medications.[Methods] The data about the post-discharge medications (≤ 1 year) of 116 patients with myocardial infarction in Wafangdian Center Hospital between 2000 and 2003 were reviewed, including antiplatelet drug, beta-blocker, angiotensin-converting enzyme inhibitor(ACEI), lipid-lowering drug and other drugs.[Results]In 108 patients (93.1%) routinely took antiplatelet drug orally;75 patients (64.7%) common took ACEI orally; 82 patients (70.7%) usually took beta-blocker orally; only 39 patients (33.6%) insisted on taking lipid-lowering drug orally;26 symptomless patients long-term took orally nitrate;24 symptomless patients long-term took Calcium antagonists(CCB).[Conclusion] Patients routinely took antiplatelet drug and beta-blocker orally ,the primary problem among which was that their dosage were low. The chief reason for the problem was that their follow-ups were not enough; The side effect of ACEI (cough) and doctors' level lowered its usage; It
is evident that patients' economic status decreased the usage and dosage of lipid-lowering drug. |
Key words: myocardial infarction standard medication investigation |